368 related articles for article (PubMed ID: 27490240)
1. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
[TBL] [Abstract][Full Text] [Related]
2. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.
Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K
Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647
[TBL] [Abstract][Full Text] [Related]
3. Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.
Levinson RD; Okada AA; Ashouri E; Keino H; Rajalingam R
Hum Immunol; 2010 Feb; 71(2):192-4. PubMed ID: 19897003
[TBL] [Abstract][Full Text] [Related]
4. KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.
Levinson RD; Du Z; Luo L; Holland GN; Rao NA; Reed EF; Rajalingam R
Hum Immunol; 2008 Jun; 69(6):349-53. PubMed ID: 18571006
[TBL] [Abstract][Full Text] [Related]
5. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
6. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.
Tiercy JM; Rathinam SR; Gex-Fabry M; Baglivo E
Mol Vis; 2010 Mar; 16():353-8. PubMed ID: 20216938
[TBL] [Abstract][Full Text] [Related]
7. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.
Beelen NA; Molenbroeck SJJ; Groeneveld L; Voorter CE; Bos GMJ; Wieten L
Immunogenetics; 2024 Jun; 76(3):155-164. PubMed ID: 38478091
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis.
Shi T; Lv W; Zhang L; Chen J; Chen H
Sci Rep; 2014 Nov; 4():6887. PubMed ID: 25382027
[TBL] [Abstract][Full Text] [Related]
9. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
10. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
[TBL] [Abstract][Full Text] [Related]
11. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke.
Tuttolomondo A; Di Raimondo D; Pecoraro R; Casuccio A; Di Bona D; Aiello A; Accardi G; Arnao V; Clemente G; Corte VD; Maida C; Simonetta I; Caruso C; Squatrito R; Pinto A;
J Neuroinflammation; 2019 Apr; 16(1):88. PubMed ID: 30995924
[TBL] [Abstract][Full Text] [Related]
12. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
13. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.
Rajalingam R
Iran J Immunol; 2007 Jun; 4(2):61-78. PubMed ID: 17652846
[TBL] [Abstract][Full Text] [Related]
14. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
15. Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population.
Sakono T; Meguro A; Takeuchi M; Yamane T; Teshigawara T; Kitaichi N; Horie Y; Namba K; Ohno S; Nakao K; Sakamoto T; Sakai T; Nakano T; Keino H; Okada AA; Takeda A; Ito T; Mashimo H; Ohguro N; Oono S; Enaida H; Okinami S; Horita N; Ota M; Mizuki N
PLoS One; 2020; 15(5):e0233464. PubMed ID: 32437414
[TBL] [Abstract][Full Text] [Related]
16. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
[TBL] [Abstract][Full Text] [Related]
17. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California.
Weisz JM; Holland GN; Roer LN; Park MS; Yuge AJ; Moorthy RS; Forster DJ; Rao NA; Terasaki PI
Ophthalmology; 1995 Jul; 102(7):1012-5. PubMed ID: 9121744
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
19. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
[TBL] [Abstract][Full Text] [Related]
20. Understanding the killer-cell immunoglobulin like receptor polymorphism in retinoblastoma.
Aggarwal R; Sharma M; Singh U; Poulton K; Bhatia T; Mangat N; Kakkar N; Bansal D
Ophthalmic Genet; 2023 Feb; 44(1):1-5. PubMed ID: 36594723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
